Ventyx Biosciences Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Ventyx Biosciences Inc in the third quarter 2025?
Ventyx Biosciences Inc recorded a cumulative net loss of $-107 million during 12 months ending in the third quarter 2025, resulting in a negative return on equity (ROE) of -48.11%.

Within the Major Pharmaceutical Preparations industry 165 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2025 from 2665 to 3225.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Equity Change	-31.35 %	-25.43 %	-24.55 %	4.15 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-107	-119	-124	-135	-153
Return On Equity (TTM)	-48.11 %	-48.89 %	-47.45 %	-48.23 %	-54.94 %
VTYX's Total Ranking	# 3225	# 2665	# 2821	# 2883	# 3048
Equity (TTM) in Millions	191	209	232	254	279
Seq. Equity Change	-8.61 %	-9.61 %	-8.82 %	-8.87 %	-0.72 %
Seq. Net Income Change	-	-	-	-	-

Back to VTYX Management Effectiveness >> VTYX's 5 Years Annual ROE >> Compare VTYX ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 166
Sector	# 397
Overall	# 3225

Return On Equity Statistics
High	Average	Low
-20.75 %	-46.69 %	-66.28 %
(Sep 30 2022)		(Mar 31 2024)

VTYX Annual Return On Equity	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	254	244	354	279	0
Y / Y Equity Change	4.15 %	-31.07 %	26.75 %	-	-
Net Income in Millions	-135	-193	-108	-84	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-53.19 %	-79.11 %	-30.64 %	-30 %	-

Back to VTYX Management Effectiveness >> VTYX's 5 Years Annual ROE >> Compare VTYX ROE to its Competitors

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
VTYX's' Return on Equity at Yahoo Finance
VTYX's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for VTYX's Competitors
Subscribers only: Roe for Ventyx Biosciences Inc 's Suppliers
Subscribers only: Return On Equity for VTYX's Customers

Companies with similar Return On Equity at Sep 30 2025, within Healthcare Sector

ROE

Date modified: 2026-09-26T07:40:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.